Safety Study of Tivanisiran to Treat Dry Eye

Clinical trial NCT05310422 · COMPLETED

Trial details

NCT number: NCT05310422
Sponsor: Sylentis, S.A.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Dry Eye Disease

Start date: 2022-03-24
Primary completion: 2023-10-11
Enrollment: 301

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.